Recent ARTL News
- Form 8-K - Current report • Edgar (US Regulatory) • 03/06/2026 01:30:28 PM
- Artelo Biosciences Announces Reverse Stock Split • GlobeNewswire Inc. • 03/06/2026 01:00:00 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 02/24/2026 01:01:07 PM
- Artelo Biosciences Provides Business Update Highlighting Clinical Progress and Reports Fiscal 2025 Year-End Financial Results • GlobeNewswire Inc. • 02/24/2026 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/05/2026 09:01:41 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/05/2026 01:00:28 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/02/2026 09:38:04 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/30/2026 09:10:27 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/16/2026 10:16:11 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 01/07/2026 09:05:48 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 09:17:04 PM
- Artelo Bioscience Commends Presidential Executive Order Expanding CBD Research and Access; Highlights ART12.11 as a Leading Pharmaceutical-Grade Cannabidiol Candidate • GlobeNewswire Inc. • 12/23/2025 02:00:00 PM
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 12/11/2025 09:14:35 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 12/11/2025 09:05:26 PM
- Artelo Biosciences Announces Publication of New Peer-Reviewed Study Demonstrating Intraperitoneal Administration of a Novel Fatty Acid Binding Protein 5 (FABP5) Inhibitor Significantly Reduces Stress-Induced Anxiety and Depression Behaviors in Preclinical • GlobeNewswire Inc. • 12/03/2025 01:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/25/2025 09:05:41 PM
- Form S-1 - General form for registration of securities under the Securities Act of 1933 • Edgar (US Regulatory) • 11/17/2025 09:56:08 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/12/2025 01:01:01 PM
- Artelo Biosciences Provides Business Update and Reports Third Quarter 2025 Financial Results • GlobeNewswire Inc. • 11/12/2025 01:00:00 PM
- Artelo Biosciences Announces Publication of Peer-Reviewed Article on Role of Fatty Acid Binding Proteins in Cancer • GlobeNewswire Inc. • 11/04/2025 01:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 12:00:49 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/27/2025 12:00:51 PM
Exxe Group Advances Platform Strategy and Share Structure Reduction Following Strategic Meetings • AXXA • Mar 11, 2026 1:03 PM
DRCR Pushes Forward With Implementation of 2026 Business Plan • DRCR • Mar 11, 2026 12:26 PM
Record Gold Prices Reshape Opportunities for Emerging Producers • LFLR • Mar 11, 2026 9:00 AM
C2 Blockchain Reports 803 Million DOG (Bitcoin) Holdings Following Strategic Accumulation of Bitcoin-Native Digital Assets • CBLO • Mar 10, 2026 8:00 AM
RENI Completes Due Diligence on Target Acquisition; Confirms Strong Asset Base and Operational Performance • RENI • Mar 5, 2026 10:15 AM
BlackStar Engages in Talks with U.S. Senate Banking Committee Team Covering the Digital Asset Market Clarity Act • BEGI • Mar 4, 2026 4:47 PM
